What Is TB-500? The Thymosin Beta-4 Fragment Explained for Researchers

TB-500 thymosin beta-4 fragment actin cell migration tissue repair research peptide Durham Peptides Canada

TB-500 is the other half of the most-studied recovery peptide pairing in research. Where BPC-157 is studied primarily for building blood supply, TB-500 is studied for a different and complementary function: getting the repair cells to the site of injury. As a synthetic fragment of the naturally occurring protein Thymosin Beta-4, TB-500 sits at the center of cell-migration and tissue-repair research, and its mechanism — regulation of the cellular protein actin — gives it a distinctive role in the healing-research landscape.

This article explains what TB-500 is, its relationship to Thymosin Beta-4, the actin-and-migration mechanism it's studied for, and how it fits recovery research. For Canadian researchers, Durham Peptides carries TB-500 10mg. Nothing here is medical, dosing, or therapeutic guidance.

The Origin: A Fragment of Thymosin Beta-4

TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4 (TΒ4) — a naturally occurring protein found in nearly all human and animal cells, present in particularly high concentrations at sites of tissue injury. Thymosin Beta-4 is one of the body's primary regulators of the protein actin, and it plays a central role in cell migration, wound healing, and tissue repair.

TB-500 corresponds to the bioactive region of Thymosin Beta-4 responsible for much of its cell-migration and repair activity. By synthesizing this active fragment, researchers can study those properties as a defined research compound. (A note on terminology: "TB-500" and "Thymosin Beta-4" are often used interchangeably in research-peptide contexts, though strictly TB-500 refers to the synthetic fragment.)

The Molecular Basics

Durham Peptides' TB-500:

• Molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S

• Molecular weight: 4963.44 g/mol

• CAS number: 77591-33-4

• Classification: Thymosin Beta-4 fragment (synthetic 43-amino-acid peptide)

At 43 amino acids and nearly 5,000 g/mol, TB-500 is a substantially larger peptide than its frequent partner BPC-157 (15 amino acids, ~1,420 g/mol) — a structural difference that reflects their different mechanisms.

The Core Mechanism: Actin Regulation and Cell Migration

The defining mechanism behind TB-500's reparative research is its regulation of actin — one of the most abundant proteins in cells and the key structural component of the cytoskeleton. Actin polymerization (the assembly of actin into filaments) is what allows cells to change shape and move. Thymosin Beta-4, and by extension TB-500, is a major regulator of this process: it binds actin monomers and influences the polymerization that drives cell motility.

Why does this matter for repair? Tissue healing requires repair cells — fibroblasts, keratinocytes, endothelial cells — to migrate to the site of injury. By upregulating actin and promoting cell migration, TB-500 is studied for its investigated ability to help mobilize these repair cells. This is the conceptual complement to BPC-157's angiogenesis mechanism: BPC-157 builds the blood supply; TB-500 moves the repair cells. Together they address two different requirements of tissue repair — the basis for combining them, covered in BPC-157 vs TB-500.

Mechanism 2: Tissue Repair Across Models

Reflecting Thymosin Beta-4's natural concentration at injury sites, TB-500 has been studied for tissue repair across muscle, tendon, and ligament models, and for its investigated role in wound recovery — including accelerated wound closure in animal studies. The breadth here parallels BPC-157, which is why the two are so often discussed together.

Mechanism 3: Anti-Inflammatory and Cardiovascular Threads

Additional research threads include TB-500's study in anti-inflammatory pathways (linked to reduction of inflammatory cytokines in preclinical research) and in cardiovascular models, where Thymosin Beta-4 has been investigated for cardiac tissue repair and remodeling. As with BPC-157, the bulk of TB-500's evidence base is preclinical.

What Researchers Examine

• Actin regulation and cellular migration pathways

• Fibroblast and keratinocyte migration in wound models

• Anti-inflammatory cytokine modulation

• Angiogenesis and blood-vessel formation in recovery models

• Synergistic effects with BPC-157 (the "Wolverine Stack" combination)

Where TB-500 Fits in Recovery Research

TB-500 anchors the healing and recovery research category alongside BPC-157. The two are studied together because their mechanisms are complementary:

• BPC-157 → angiogenesis (blood-supply building)

• TB-500 → cell migration (actin regulation)

This is why Durham Peptides offers both individually and pre-blended in the Wolverine Stack, and why TB-500 also appears in the multi-peptide Glow Blend alongside GHK-Cu and BPC-157. For the category overview, see Healing & Recovery Peptides Explained.

Quality and Storage

Durham Peptides' TB-500 is supplied as a 10mg lyophilized peptide, Janoshik-verified to ≥99% purity by HPLC with mass-spec identity confirmation, 100% synthetically manufactured (vegan). Storage: 2–8°C, protected from light and moisture; reconstitute in bacteriostatic water. See How to Read a Janoshik COA and the peptide calculator for reconstitution math.

Frequently Asked Questions

What is TB-500? A synthetic 43-amino-acid peptide based on a fragment of Thymosin Beta-4, studied for tissue repair through actin regulation and cell migration.

Is TB-500 the same as Thymosin Beta-4? They're closely related and often used interchangeably, but strictly TB-500 is the synthetic fragment corresponding to the bioactive, cell-migration region of the full Thymosin Beta-4 protein.

What is TB-500 studied for? Primarily actin regulation and cell migration, plus tissue repair in muscle/tendon/ligament models, wound recovery, and anti-inflammatory and cardiovascular pathways — largely in preclinical models.

How is TB-500 different from BPC-157? TB-500 is studied primarily for cell migration (actin regulation); BPC-157 is studied primarily for angiogenesis (blood-vessel formation). Complementary mechanisms, which is why they're combined.

Why is TB-500 so much larger than BPC-157? TB-500 is a 43-amino-acid fragment (~4963 g/mol) versus BPC-157's 15 amino acids (~1420 g/mol), reflecting their different origins and mechanisms.

Where can I buy TB-500 in Canada? Durham Peptides supplies TB-500 10mg for laboratory use only, Janoshik-verified and shipped same-day from Ontario.

Final Thoughts

TB-500 completes the recovery-research picture that BPC-157 begins. Through its regulation of actin and promotion of cell migration, it addresses a different requirement of tissue repair than BPC-157's angiogenesis — and the two together form the most-studied combination in recovery peptide research. As with BPC-157, the evidence is largely preclinical, so TB-500 is best understood as a research compound of strong mechanistic interest.

For Canadian researchers, Durham Peptides supplies TB-500 10mg at C$80.00. For its research partner, see What Is BPC-157?; for the head-to-head, see BPC-157 vs TB-500; and for the category, see Healing & Recovery Peptides Explained.

Selected Research References

1. Goldstein AL, Hannappel E, Kleinman HK. Thymosin Beta-4: Actin-Sequestering Protein Moonlights to Repair Injured Tissues. Trends in Molecular Medicine. 2005;11(9):421-429. https://pubmed.ncbi.nlm.nih.gov/16099219/

2. Malinda KM, Sidhu GS, Mani H, et al. Thymosin Beta-4 Accelerates Wound Healing. Journal of Investigative Dermatology. 1999;113(3):364-368. https://pubmed.ncbi.nlm.nih.gov/10469335/

3. Philp D, Kleinman HK. Animal Studies with Thymosin Beta-4, a Multifunctional Tissue Repair and Regeneration Peptide. Annals of the New York Academy of Sciences. 2010;1194:81-86. https://pubmed.ncbi.nlm.nih.gov/22074294/

All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.